Autobio Diagnostics Co., Ltd. (SHA:603658)
37.31
+0.47 (1.28%)
At close: Jan 23, 2026
Autobio Diagnostics Market Cap
Autobio Diagnostics has a market cap or net worth of 21.32 billion as of January 23, 2026. Its market cap has decreased by -16.07% in one year.
Market Cap
21.32B
Enterprise Value
20.61B
Revenue
4.22B
Ranking
n/a
PE Ratio
19.45
Stock Price
37.31
Market Cap Chart
Since September 1, 2016, Autobio Diagnostics's market cap has increased from 8.82B to 21.32B, an increase of 141.72%. That is a compound annual growth rate of 9.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 21.32B | 5.34% |
| Dec 31, 2025 | 20.24B | -18.93% |
| Dec 31, 2024 | 24.97B | -24.62% |
| Dec 29, 2023 | 33.12B | -8.65% |
| Dec 30, 2022 | 36.26B | 12.33% |
| Dec 31, 2021 | 32.28B | -50.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lepu Medical Technology (Beijing) | 34.79B |
| APT Medical | 34.20B |
| MGI Tech | 29.15B |
| Double Medical Technology | 20.39B |
| MeHow Innovative | 19.29B |
| Shandong Weigao Blood Purification Products | 17.39B |
| Jafron Biomedical | 16.02B |
| Beijing Balance Medical Technology | 15.28B |